Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Xvivo Perfusion AB (publ) XVIPY

Full chart Compare
Set alert

Price alert · XVIPY

All alert types
5.50 USD +5.23 (+1,924.69%)

At closeSep 30, 2026, 4:00 PM EDT

5.50 Day range 5.50
4.25 52-week range 8.18
YTD
+19.57%
1 year
-33.49%

Revenue & Expenses

Revenue → Gross Profit: $501.48MGross Profit → Net Income: $23.65MGross Profit → Selling, General & Admin: $319.40MGross Profit → Research & Development: $94.65MRevenue → Cost of Revenue: $261.95MGross Profit → Interest Expense: $4.32MGross Profit → Other Expenses: $46.86MGross Profit → Income Tax: $12.59MGross Profit$501.48MCost of Revenue$261.95MNet Income$23.65MSelling, General & Admin$319.40MResearch & Development$94.65MInterest Expense$4.32MOther Expenses$46.86MIncome Tax$12.59MRevenue$763.43M

No annual statement lines

XVIPY has no annual lines for this statement.